The Affordable Care Act was designed to restructure the individual insurance market into a true insurance risk pool. President Obama should stop pretending those changes won’t affect everyone in the individual market, whether they want it to or not.
Chief Deputy Insurance Commissioner Logan Harrison says the Department of Insurance doesn't yet know whether state regulators have the legal authority to approve reversals.
The messy rollout of the insurance exchanges has made it hard for carriers to figure out what business will be like in 2014.
The move includes a $45 million investment for Lilly's operations in Indianapolis, on top of $400 million in investments the company announced over the past two years.
The administration says fewer than 27,000 people managed to enroll for health insurance last month in the 36 states relying on the problem-filled federal website for President Barack Obama’s overhaul.
Eli Lilly and Co. and Pfizer Inc., which are both suffering through some of the largest patent cliffs in the industry, will split any future costs and profits of an osteoarthritis drug that has stalled in clinical testing.
Testosterone replacement drugs, a $1.6 billion market for Eli Lilly and Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapy's cardiovascular risks.
Indianapolis-based Eli Lilly and Co., Bayer AG and Boehringer Ingelheim GmbH are among companies that may consider an offer if the Swiss drugmaker proceeds with the animal-health sale.
U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.
Indiana officials don’t expect HealthCare.gov to be able to share individual account information with the state’s Medicaid computer systems until the end of the year.
Obamacare put an end to health insurers’ worst methods for avoiding risk. But that doesn’t mean insurers have ended their risk-shifting ways. Not at all.
State officials announced Thursday that they will extend Indiana’s high-risk insurance pool through the end of January to accommodate Hoosiers who have been unable to enroll in coverage through the federal marketplace.
Hoosiers’ poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
So-called “zero-premium plans” are priced in such a way that their premiums would be no greater than the federal tax subsidies that low-income buyers could claim.
San Francisco-based Genstar Capital is exploring selling the 2,600-employee company in the wake of failing early this year to renegotiate the company’s massive debt load.
Why are Indiana’s hospitals cutting jobs. Because they’re spooked about cuts to Medicare payments. They should be.
Premiums written by the firm’s insurance subsidiaries hit $96.6 million, an increase of nearly 19 percent over the third quarter a year ago and 4 percent over the second quarter.
Today’s specialty medications are modern miracles, helping millions of patients with chronic, life-threatening illnesses such as cancer, multiple sclerosis and rheumatoid arthritis.
With a $60 million-plus investment, the university aims to take molecules from discovery to clinical trials.
Eli Lilly and Co. has been counting on torrid growth in China to help offset losses from patent expirations in other markets, but now slower growth in the Chinese economy and bribery allegations against Lilly and two other drugmakers have hampered Lilly’s growth there.
